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A B S T R A C T
Active virus-host interactions determine the outcome of pathogen invasions. It has been shown that in isolated
dendritic cells (DCs), rotavirus can induce the expression of tumor necrosis factor α (TNF-α), a vital cytokine
mediating host immune responses. However, the role of TNF-α in rotavirus infection is unknown. In this study,
we demonstrated that TNF-α has potent anti-rotavirus eﬀects, independent of type I interferon production.
Blocking of TNF-α by inﬂiximab, a clinically available TNFα antibody, totally abrogated this eﬀect. Mechanistic
studies revealed that the anti-rotavirus eﬀect of TNF-α was achieved by NFκB-regulated genes via the activation
of classical nuclear factor κB (NF-κB) signaling. Our study reveals the pivotal role and the mechanism-of-actions
of TNF-α in the host defense against rotavirus. Thus, this knowledge may contribute to the better understanding
of the complexity of rotavirus-host interactions.
1. Introduction
Rotavirus is a viral pathogen that causes severe gastroenteritis
worldwide, especially in children under ﬁve years of age (Tate et al.,
2012). It is also prevalent in immunocompromised patients, such as
pediatric and adult organ transplant recipients (Yin et al., 2015b).
Notably, gastrointestinal infections including rotavirus have been re-
cognized as potential cause of exacerbation and induction of ﬂares in
inﬂammatory bowel disease (IBD) patients (Masclee et al., 2013). Ro-
tavirus primarily infects mature enterocytes at the tips of the intestinal
villus, leading to acute diarrhea (Greenberg and Estes, 2009). However,
systemic infections can occur which involve multiple extra-intestinal
organs, including liver, kidney and the central nervous system
(Chiappini et al., 2005).
The innate and adaptive immune systems play an essential role in
the limitation of rotavirus infection in infected hosts (Angel et al., 2012;
Holloway and Coulson, 2013). Rotavirus can induce the production of
interferons (IFNs) and cytokines, including interferon α (IFN-α), IFN-β,
tumor necrosis factor α (TNF-α), interleukin 6 (IL-6) and also IL-8 in
dendritic cells (DCs) (Deal et al., 2010; Mesa et al., 2007; Rosales-
Martinez et al., 2016). Previous studies have demonstrated a role for
the diﬀerent types of IFNs in constraining rotavirus infection
(Hernandez et al., 2015; Lin et al., 2016; Saxena et al., 2017). In ad-
dition, we have previously shown that rotavirus modulates the ex-
pression of interferon-stimulated genes (ISGs) that cooperatively med-
iate an anti-viral state in the infected cells (Yin et al., 2015a). On the
other hand, rotavirus eﬃciently develops strategies to counteract these
anti-viral responses (Arnold et al., 2013; Ding et al., 2016), indicating
an active and dynamic virus-host interplay following infection.
TNF-α was ﬁrst described as a serum factor that mediates killing of
tumors in vitro, from which it derives its name (Carswell et al., 1975).
Further studies discovered that TNF-α is a potent and essential mediator
of inﬂammatory responses. Aberrant regulations of TNF-α have been
associated with many immune-mediated inﬂammatory diseases, such as
rheumatoid arthritis (RA) and IBD. This has led to the development of
therapeutic agents targeting TNF-α that are now successfully used in
the clinic (Kalliolias and Ivashkiv, 2016; Sedger and McDermott, 2014).
However, these TNF-α antagonists are well known to increase the risk
of severe viral (including rotavirus) and bacterial infections, thus lim-
iting their use in groups of patients (Kim and Solomon, 2010; Sedger
and McDermott, 2014). This phenomenon highlights the fact that TNF-
α has either direct or indirect eﬀects against bacterial and viral
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infections. Indeed, several studies have demonstrated the anti-viral and
anti-bacterial properties of TNF-α against inﬂuenza virus (Seo and
Webster, 2002), hepatitis C (HCV) and E (HEV) viruses (Wang et al.,
2016), poxviruses (Bartee et al., 2009), and Mycobacterium tuberculosis
(Flynn et al., 1995), either alone or in combination with IFNs.
However, the potential activity of TNF-α on rotavirus has not yet
been described. Here we report that TNF-α has potent anti-viral eﬀects
against rotavirus. However, its anti-rotavirus eﬀect is totally in-
dependent of interferon production and the IFN signaling pathway.
Importantly, these eﬀects are achieved by the induction of NFκB-
regulated genes through the activation of classical nuclear factor κB
(NF-κB) signaling. This study therefore strengthens the role of TNF-α as
a host immune response in defending against viral infections.
2. Materials and methods
2.1. Reagents
Recombinant human TNF-α (Peprotech, USA) was dissolved in
phosphate-buﬀered saline (PBS) to a ﬁnal concentration of 100 μg/mL.
Human recombinant IL32 A (GeneTex), IL8 (Abnova), CXCL10
(BioLegend), CXCL11 (BioLegend), CCL20 (BioLegend) and CCL2
(BioLegend) was dissolved to a ﬁnal concentration of 10 μg/mL. Stock
of JAK I inhibitor (Santa Cruz Biotech, CA) was dissolved in dimethyl
sulfoxide (DMSO) (Sigma-Aldrich, St Louis, MO, USA) with a ﬁnal
concentration of 5mM. ReIA (p65) antibody (C22B4, #4764) was
purchased from Cell Signaling Technology (Leiden, The Netherlands).
β-actin and TNFR1 antibody (sc-8436) were purchased from Santa Cruz
Biotechnology. β-tubulin antibody (ab6046) was purchased from
Abcam. Anti-VP4 mouse monoclonal antibody (HS-2) was generously
provided by Professor Harry Greenberg (Standford University School of
Medicine, USA). Anti-rabbit or anti-mouse IRDye-conjugated antibodies
were used as secondary antibodies for western blotting (Stressgen,
Victoria, BC, Canada).
2.2. Rotavirus SA11 and human-derived strain
A well-characterized and broadly used laboratory strain, simian
rotavirus SA11, was employed. SA11 rotavirus strain used in this study
was prepared as previously described (Knipping et al., 2012). Rotavirus
genome copy numbers were determined by quantitative real-time
polymerase chain reaction (qRT-PCR) referring to a plasmid template
using a standard curve calculation method as described previously (Yin
et al., 2015a). A standard curve was generated by plotting the log copy
number versus the cycle threshold (CT) value (Supplementary Fig. S1).
Human rotavirus (huRV) strains were isolated form rotavirus diarrhea
patients as described previously (Yin et al., 2015a).
2.3. Cell culture
Caco2 cell line (human caucasian colon adenocarcinoma ECACC)
was cultured in Dulbecco’s modiﬁed Eagles’s medium (DMEM; Lonza,
Verviers, Belgium) supplemented with 20% (vol/vol) heat-inactivated
fetal calf serum (FCS; Sigma-Aldrich, St. Louis USA), 100 U/mL peni-
cillin and 100 U/mL streptomycin (Gibco, Grand Island, USA). The cells
were maintained in 5% CO2 at 37 °C in a humidiﬁed incubator.
2.4. Inoculation of SA11 and huRV rotavirus and treatment
Caco2 cell lines (not diﬀerentiated) maintained in T75 ﬂasks were
suspended and subsequently seeded into 48-well plates (5 * 104 cells/
well) in DMEM containing 20% (vol/vol) FCS and 100 U/mL penicillin-
streptomycin. When the cell conﬂuence was approximately 80% after
2–3 days of culture, culture medium was discarded. The cell monolayer
was then washed twice with PBS. 100 μL of serum-free DMEM medium
containing 5 μg/mL of trypsin (Gibco, Paisley, UK) and SA11 rotavirus
(MOI 0.7) were added and incubated at 37 °C with 5% CO2 for 60min
for infection, followed by three times washing with PBS to remove free,
uninfecting virus particles. Subsequently, the cells were added with
serum-free culture medium containing 5 μg/mL of trypsin (and in-
dicated treatments) and incubated at 37 °C with 5% CO2 for 48 h.
Inoculation protocol of huRV strains is similar to inoculation of SA11
rotavirus.
2.5. Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was isolated with a Machery-NucleoSpin RNA II kit
(Bioke, Leiden, The Netherlands) and quantiﬁed using a Nanodrop ND-
1000 (Wilmington, DE, USA). cDNA was prepared from total RNA using
a cDNA Synthesis Kit (Takara Bio Inc) with random hexamer primers.
qRT-PCR was performed with a SYBRGreen-based real-time PCR (MJ
Research Opticon, Hercules, CA, USA) according to the manufacturer’s
instructions. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
gene was considered as a reference gene to normalize gene expression.
Relative gene expressions were normalized to GAPDH using the formula
2-ΔΔCT (ΔΔCTsample – ΔΔCTcontrol). The SA11 rotavirus sense and anti-
sense primers target 564–585 and 719-699 of the VP6 segment of SA11
genome, respectively. All primers used in this study are listed in
Supplementary Table S1.
2.6. IFN production bioassay
The IFN production bioassay was performed to detect secreted IFN
proteins in the culture medium as described previously (Xu et al.,
2016). Caco2 cells were seeded into 48-well plates and stimulated with
TNF-α 10 ng/mL. After 24 h, medium was removed and the cell
monolayer was washed three times with PBS. Subsequently, the
medium was refreshed and cultured for another 24 h to let the produced
IFNs secreted into the medium. The culture (conditioned) medium were
then collected and ﬁltered through 0.45 μm pore size membrane. To
detect the presence of IFNs, Huh7-ISRE-luc reporter cell lines was used.
Huh7-ISRE-luc is a luciferase reporter model in which the ﬁreﬂy luci-
ferase gene was driven by multiple IFN-stimulated response elements
(ISRE) promoter. In this model, the ﬁreﬂy luciferase activity can be
potently stimulated by a low concentration of IFN-α treatment. Huh7-
ISRE-luc cells were cultured in DMEM supplemented with 10% FCS
(vol/vol), 100 U/mL penicillin and streptomycin.
2.7. Gene knockdown using lentiviral vectors
Lentiviral pLKO knockdown vectors (Sigma-Aldrich) targeting
TNFR1 and ReIA (p65) or scrambled control, were obtained from the
Erasmus Center of Biomics and produced in human embryonic kidney
epithelial cell line HEK 293 T cells as described previously (Pan et al.,
2009). After a pilot study, the shRNA vectors exerting optimal gene
knockdown were selected. All shRNA sequences are listed in Supple-
mentary Table S2. As the lentiviral vectors also encode a puromycin
resistance gene, transduced cells were subsequently selected by adding
puromycin (8 μg/mL; Sigma) to the cell culture medium. Knockdown
and control Caco2 cells were infected with rotavirus SA11 as previously
described.
2.8. Caco2-based NF-κB and AP-1 luciferase reporter cell lines and
measurement of luciferase activity
NF-κB and AP-1 luciferase reporter cells were generated by trans-
ducing Caco2 cells with lentiviral vectors expressing the ﬁreﬂy luci-
ferase gene under the control of the promoters containing the NF-κB
and AP-1 motifs, respectively (System Biosciences).
To measure the luciferase activity, luciferin potassium salt
(100mM; Sigma) was added to the cells and incubated for 20min at
37 °C. The luciferase activity was quantiﬁed with a LumiStar Optima
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luminescence counter (BMG Lab Tech, Oﬀenburg, Germany).
2.9. Western blot assay
After discarding the culture medium (supernatants), cultured cells
were lysed in Laemmli sample buﬀer containing 0.1 M DTT and heated
for 5min at 95 °C, followed by loading onto a 10% sodium dodecyl
sulfate polyacrylamide gel and separation by electrophoresis (SDS-
PAGE). After 90min. running at 120 V, proteins were electro-
phoretically transferred onto a polyvinylidene diﬂuoride (PVDF)
membrane (Immobilon-FL) for 1.5 h with an electric current of 250mA.
Subsequently, the membrane was blocked with a mixture of 2.5 ml
blocking buﬀer (Odyssey) and 2.5 ml PBS containing 0.05% Tween 20,
followed by overnight incubation with primary antibodies (1:1000) at
4 °C. The membrane was then washed 3 times, followed by incubation
for 1 h with IRDye-conjugated secondary antibody (1:5000). After
washing 3 times, protein bands were detected with the Odyssey 3.0
Infrared Imaging System.
2.10. Enzyme-linked immunosorbent assay (ELISA)
Serum samples were collected from Crohn’s disease patients and
stored at −80 °C. Serum TNF-α levels were measured by an ELISA kit
(eBioscience, USA) according to the manufacturer’s instructions. The
absorbance value was measured at 450 nm in an automatic microplate
reader. The results were calculated based on a standard curve.
2.11. MTT assay
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) (Sigma) (10mM) was added to Caco2 cells cultured in 96-well
plates at indicated time points (24 and 48 h) following TNF-α and cy-
tokine treatments. The cells were then incubated at 37 °C with 5% CO2
for 3 h. Subsequently, the culture medium was removed and 100 μl of
dimethyl sulfoxide (DMSO) was added to each well. The absorbance of
each well was measured on the microplate absorbance readers (BIO-
RAD) at the wavelength of 490 nm.
2.12. Immunoﬂuorescence and confocal microscope assay
Caco2 cells were seeded on glass coverslips in 6-well plates. Then,
Caco2 cells were infected with SA11 for 48 h. Subsequently, cells were
washed with PBS, ﬁxed in 4% PBS-buﬀered formalin for 10min. and
blocked with tween-milk-glycine medium (PBS, 0.05% tween, 5 g/L
skim milk and 1.5 g/L glycine). Samples were incubated with 1:500
dilution of anti-rotavirus (ab181695) antibody (Abcam) overnight at
4 °C. Subsequently, samples were incubated with 1:1000 dilution of
Alexa FluorTM 594 goat anti-mouse secondary antibodies (Invitrogen).
Nuclei were stained with DAPI (4,6-diamidino-2-phenylindole;
Invitrogen). Finally, the images were detected using immuno-
ﬂuorescence microscope.
For analysis of ReIA protein, Caco2 cells on glass coverslips in 6-well
plates were infected with either mock, SA11, huRV 1 and huRV 2 ro-
tavirus for 8 h. Subsequently, cells were washed twice with PBS. The
mock- or rotavirus-infected cells were then stimulated with TNF-α
(100 ng/mL) for 1 h. Fixed and permeabilized cells were stained with
antibodies to ReIA (C22B4, #4764, Cell Signaling Technology, Leiden,
The Netherlands), followed by anti-rabbit IgG(H+L),F(ab') 2 Fragment
(Alexa Fluor 488 conjugate) secondary antibodies. The ReIA proteins
were visualized with confocal microscopy. Nuclei were stained by DAPI
(blue).
2.13. Statistical analysis
Statistical analysis was performed using the nonpaired, nonpara-
metric test (Mann-Whitney test; GraphPad Prism software, GraphPad
Software Inc., La Jolla, CA). P values< 0.05 were considered statisti-
cally signiﬁcant.
2.14. Ethical statement
The use of serum samples from IBD patients was approved by the
Medical Ethical Committee of the Erasmus Medical Center (Medisch
Ethische Toetsings Commissie Erasmus MC). Informed consents were
signed by the volunteers or patients who agreed to participate.
3. Results
3.1. TNF-α has potent anti-viral activity against rotavirus
TNF-α serves as a host immune response against a variety of pa-
thogen invasions. It has been previously reported that virus infection,
such as inﬂuenza virus, induces TNF-α expression in lung epithelial
cells, which subsequently inhibits inﬂuenza virus replication (Seo and
Webster, 2002). To investigate whether rotavirus infection can also
induce tnfa gene transcription, we employed the widely used Caco2
intestinal epithelium cell line. Infection of these cells with SA11 rota-
virus did not trigger transcription of tnfa gene at 6, 24, 36 and 48 h
post-infection (Supplementary Fig. S2A). In addition, analysis of IL1B
and IL8 gene expression levels showed that there were no changes of
these genes upon rotavirus infection in Caco2 cells (Supplementary Fig.
S2B and C). This ﬁnding, which is in agreement with previous studies
(Cuadras et al., 2002), suggests that in our experimental system, Caco2
cells cells do not produce TNF-α upon rotavirus infection.
Since rotavirus does not stimulate tnfa gene transcription in Caco2
cells, we next investigated the eﬀects of exogenous TNF-α treatment on
rotavirus replication. Treatment of SA11 rotavirus-infected Caco2 cells
with human recombinant TNF-α for 24 and 48 h signiﬁcantly inhibited
viral RNA levels. At concentrations of 10 and 100 ng/mL for 24 h, TNF-
α decreased total viral RNA levels by 41 ± 8% (P< 0.05) and
61 ± 4% (P< 0.01), respectively (Fig. 1A). The inhibitions were more
pronounced at 48 h after infections, where TNF-α decreased total viral
RNA levels by 67 ± 5% (P< 0.01) and 71 ± 4% (P< 0.01) at
concentrations of 10 and 100 ng/mL, respectively (Fig. 1A). In addition,
intracellular viral RNA levels quantiﬁed at 48 h post-infections were
signiﬁcantly reduced by 92 ± 0.3% (P< 0.001) and 92 ± 2% (P<
0.001) at 10 and 100 ng/mL, respectively (Fig. 1B). These inhibitions
were also more potent than those at 24 h, where TNF-α inhibited
55 ± 7% (P< 0.01) and 70 ± 4% (P< 0.001) of intracellular viral
RNA levels at concentrations of 10 and 100 ng/mL, respectively
(Fig. 1B). Consistently, human TNF-α signiﬁcantly reduced rotavirus
secretion by the infected Caco2 cells as shown in viral titer quantiﬁ-
cation (Fig. 1C). A notable reduction was also shown in the western blot
analysis of VP4 protein (Fig. 1D) and immunoﬂuorescence analysis of
VP6 protein of SA11-infected Caco2 cells (Fig. 1E). Importantly, MTT
assay demonstrated that TNF-α did not exert cytotoxicity to Caco2 cells
(Supplementary Fig. S3A).
It is well-known that TNF-α is involved in IBD pathogenesis and is
associated with the disease’s activity. TNF-α may inﬂuence the ex-
pression of pro-inﬂammatory genes in IBD patients (Slebioda and
Kmiec, 2014). To get further insight about the role of TNF-α in rota-
virus infection, we collected serum samples from anti-TNF-α naïve
Crohn’s disease patients. The serum TNF-α levels were measured by
ELISA and 4 serum samples with relatively high TNF-α levels were
selected (Supplementary Fig. S4A). Notably, all selected serum samples
exerted anti-rotavirus eﬀect (as determined by total viral RNA levels) as
compared to the control serum (Supplementary Fig. S4B). These results
suggest that TNF-α may indirectly inﬂuence rotavirus infection.
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3.2. Anti-rotavirus eﬀect of TNF-α is independent of interferon production
and JAK-STAT pathway activity
Since TNF-α can induce type I IFNs in several cell lines, we ﬁrst
investigated the straightforward possibility that TNF-α merely induces
IFN-α and IFN-β expression to mediate its anti-rotavirus eﬀect in Caco2
cells. As demonstrated by qRT-PCR, basal constitutive expression of
IFN-α and IFN-β is low, compared to the reference genes GAPDH
(Fig. 2A). In addition, TNF-α treatment for 48 h did not signiﬁcantly
increase IFN-α and IFN-β1 (Fig. 2B) gene expression. To further conﬁrm
the absence of IFN production in our experimental systems, the con-
ditioned medium from the TNFα-stimulated cells were collected and
were used to perform an IFN production bioassay. We used Huh7-ISRE-
luciferase reporter cell lines, in which the ﬁreﬂy luciferase gene ex-
pression is driven by multiple IFN-stimulated response elements (ISRE)
promoter. As shown in Fig. 2C, the conditioned medium was not able to
stimulate IFN response and conﬁrmed the absence of IFN proteins se-
creted in the culture medium.
Type I IFNs signal through activation of the Janus Kinases (JAKs)
protein which leads to phosphorylation of Signal Transducers and
Activators of Transcription (STAT) family of proteins. This JAK-STAT
signaling ultimately promotes expression of IFN-stimulated genes
(ISGs) as the ultimate anti-viral eﬀector molecules (Wang et al., 2017).
To further rule out the possibility of JAK-STAT pathway involvement,
we combined TNF-α with pan-JAK I inhibitors which potently block
JAK-STAT signaling (Wang et al., 2016). Consistently, addition of JAK I
inhibitor (5 μM) did not abolish the anti-rotavirus eﬀects of TNF-α
(Fig. 2D).
3.3. TNF receptor 1 is essential for TNF-α induced anti-rotavirus eﬀect
TNF-α exerts its biological eﬀect through interaction with two dif-
ferent receptors expressed in the target cells, TNF receptor 1 (TNFR1)
and TNFR2. TNFR1 is ubiquitously expressed by almost all human tis-
sues and can be activated by both soluble and transmembrane TNF-α. In
contrast, TNFR2 expression is limited to certain cell types, such as
immune cells, mesenchymal stem cells and endothelial cells (Kalliolias
and Ivashkiv, 2016). In addition, it is suggested that TNFR2 can only be
Fig. 1. Anti-rotavirus eﬀects of TNF-α. TNF-
α treatment (10 and 100 ng/mL) signiﬁcantly
inhibits rotavirus replication as measured by
total (A), intracellular (B) and extracellular
(secreted) (C) rotavirus RNA levels in Caco2
cells both at 24 and 48 h post-infections
(n= 6–8, means ± SEM; (*P<0.05;
**P<0.01; ***P<0.001; Mann-Whitney
test). (D) Western blot analysis of VP4 protein
indicates inhibitory eﬀect of 10 and 100 ng/mL
TNF-α against rotavirus at 24 and 48 h post-
infections. (E) Immunoﬂuorescence staining of
VP6 rotavirus protein (red) after 48 h infection
of Caco2 cells with rotavirus SA11. Nuclei were
visualized by DAPI (blue) (For interpretation of
the references to colour in this ﬁgure legend,
the reader is referred to the web version of this
article).
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activated by transmembrane TNF-α. Thus, TNFR1 serves as the major
signaling component for soluble TNF-α in vivo (Kalliolias and Ivashkiv,
2016). Therefore, this encouraged us to investigate whether anti-rota-
virus eﬀects of TNF-α was mediated via TNFR1.
First, Caco2 cells were transduced with integrating lentiviral vectors
expressing shRNA that speciﬁcally target TNFR1. Among three tested
shRNA vectors, sh-96 vector showed the most potent gene silencing
capacity, as determined by qRT-PCR (Fig. 3A) and western blot analysis
(Fig. 3B). As expected, TNFα-induced CXCL10 expression was abolished
in TNFR1 knockdown cells which was examined at 6 h following TNF-α
stimulation (Fig. 3C). Caco2 cells with sh-96 TNFR1 knockdown and
scrambled sh-RNA (sh-CTR) as control were subsequently infected with
SA11 rotavirus. In sh-CTR transfected cells, treatment with 10 ng/mL
TNF-α signiﬁcantly reduced viral RNA levels (80 ± 2.4% inhibition;
P<0.001). However, the anti-rotavirus eﬀect of TNF-α was abolished
upon TNFR1 silencing (Fig. 3D). To validate these results, the clinically
used anti-TNFα antibody, inﬂiximab (Remicade®), was used. Inﬂiximab
binds speciﬁcally to TNF-α and blocks its interaction with TNF re-
ceptors (Sedger and McDermott, 2014). As expected, inﬂiximab eﬃ-
ciently abrogated TNFα-induced CXCL10 expression at 6 h after sti-
mulation (Fig. 3E). Consistently, combining TNF-α with inﬂiximab
completely blocked the anti-rotavirus eﬀects of TNF-α at 48 h after
infections (Fig. 3F).
3.4. TNF-α mediates anti-rotavirus activity through NF-κB signaling
At the cellular level, binding of TNF-α to TNFR1 activates down-
stream c-JUN N-terminal kinase (JNK), leading to the transcription of
AP-1 target genes. Additionally, TNFR1 activates NF-κB, resulting in
induced expression of NF-κB target genes (Cabal-Hierro and Lazo,
2012). To dissect whether the anti-rotavirus eﬀects of TNF-α are
mediated via the AP-1 or NF-κB pathway, we ﬁrst constructed Caco2-
based stable NF-κB and AP-1 driven luciferase reporter cell lines. As
shown in Fig. 4A, TNF-α stimulation resulted in profound induction NF-
κB driven luciferase activity in a dose-dependent manner at 12, 24 and
48 h after stimulation, yet no eﬀect on AP-1 driven luciferase activity
was observed. Noteworthy, the maximum induction of NF-κB driven
luciferase activity was observed at 12 h after stimulation (Fig. 4A).
Based on these results, we hypothesized that the anti-rotavirus eﬀects of
TNF-α on Caco2 cells are mediated via the classical NF-κB signaling
pathway, rather than the AP-1 pathway.
The endpoint of TNF-α signaling is activation of the heterodimeric
NF-κB complex, consisting of the ReIA (p65) and p50 (Cabal-Hierro and
Lazo, 2012). To examine the role of this ReIA (p65)-p50 complex in
mediating anti-rotavirus eﬀects of TNF-α, Caco2 cells were transduced
with integrating lentiviral shRNA vectors to silence ReIA. Two of the
three tested shRNA vectors targeting ReIA profoundly downregulate
ReIA both at mRNA and protein level (Fig. 4B and C). Importantly, ReIA
knockdown promoted SA11 rotavirus replication by 2.2 ± 0.3 fold
(P<0.01) (Fig. 4D), supporting its importance in the control of rota-
virus infection. In ReIA knockdown cells, induction of CXCL10 ex-
pression was eﬃciently blocked following TNF-α (10 ng/mL) stimula-
tion for 6 h (Fig. 4E). Next, Caco2 cells with sh-10 ReIA knockdown and
scrambled sh-RNA as control (sh-CTR) were infected with SA11 rota-
virus with and without treatment of 10 ng/mL of TNF-α. As before,
treatment of sh-CTR transfected cells with 10 ng/mL TNF-α sig-
niﬁcantly decreased viral RNA levels (60 ± 6.5% inhibition;
P<0.001). However, this anti-rotavirus eﬀect was abrogated in ReIA
knockdown cells (Fig. 4F), demonstrating that NF-κB signaling pathway
is essential to mediate anti-rotavirus eﬀects of TNF-α.
3.5. TNFα-induced cytokines are the downstream eﬀectors to exert anti-
rotavirus activity
Following TNF-α stimulation, the activated p65:p50 NF-κB complex
translocates to the nucleus where it binds to speciﬁc DNA motifs located
in the promoter region of its target genes. This event will regulate, ei-
ther induce or suppress, the expression of TNFα-modulated genes in a
cell-type-speciﬁc manner (Kalliolias and Ivashkiv, 2016). These NFκB-
regulated genes play an essential role in the host immune response such
Fig. 2. Anti-rotavirus eﬀect of TNF-α is in-
dependent of interferon and the JAK-STAT
signaling. (A) The relative basal IFN-α and
IFN-β1 expression levels of Caco2 cell lines
were determined by qRT-PCR. GAPDH served
as a reference gene. (B) IFN-α and IFN-β1 gene
expression levels in Caco2 cells were not in-
duced following 10 ng/mL TNF-α stimulation
for 48 h as quantiﬁed by qRT-PCR (n= 12). (C)
ISRE ﬁreﬂy luciferase activity in Huh7-ISRE-luc
model treated with the conditioned medium for
48 h (n= 11). (D) JAK I inhibitor (5 μM) did
not abolish the anti-rotavirus eﬀects of TNF-α
at 48 h post-infections (n= 6). Data are pre-
sented as means ± SEM (*P<0.05;
***P<0.001; ns, not signiﬁcant; Mann-
Whitney test).
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as pro-inﬂammatory cytokine and chemokine regulation. Therefore, we
examined a panel of cytokines and chemokines which may be induced
by human TNF-α in Caco2 cell lines.
As shown in Fig. 5A, 10 ng/mL TNF-α stimulation for 6 and 24 h led
to increased transcription of the genes encoding IL-8, IL-32, CCL2,
CCL20, CXCL10 and CXCL11 genes in Caco2 cells. To dissect whether
these TNFα-induced cytokines could inhibit rotavirus infection, we
treated SA11-infected Caco2 cells with those cytokines at a con-
centration of 10 ng/mL. As shown in Fig. 5B, treatment with IL32, IL8,
CXCL11 and CCL20 potently inhibited rotavirus replication as mea-
sured by qRT-PCR. Western blot analysis of VP4 protein conﬁrmed
these results (Fig. 5C). Importantly, MTT assay revealed that these cy-
tokines did not aﬀect cell growth and cytotoxicity to Caco2 cells
(Supplementary Fig. S3B). These results collectively show that TNFα-
induced cytokines exert a powerful anti-rotavirus activity.
3.6. Sensitivity of human rotavirus (huRV) derived from clinical strains to
TNF-α treatment
Previous studies have indicated that several rotavirus strains,
including Wa (human), RRV (simian), and OSU (porcine), have dif-
ferent mechanisms of antagonizing NF-κB activation. Those mechan-
isms include degradation of β-TrCP and inhibition the nuclear trans-
location of NF-κB (Graﬀ et al., 2009; Holloway et al., 2009). To extend
our results, we employed human rotavirus (huRV)-derived clinical
strains isolated from two diarrhea patients (Yin et al., 2015a). Caco2
cells infected with two huRV-derived clinical strains were treated with
TNF-α 100 ng/mL for 48 h. As shown in Fig. 6, huRV strain 1 replica-
tion was notably inhibited by TNF-α treatment (70 ± 6% inhibition;
P<0.01), in contrast to huRV strain 2 which was resistant to TNF-α
treatment. These results suggest that huRV strains have diﬀerent sen-
sitivity to TNF-α treatment.
To further investigate the diﬀerent sensitivity of rotavirus strains
against TNF-α treatment observed in our study, we analyzed the ability
of diﬀerent rotavirus strains to block translocation of ReIA to the nu-
cleus (Supplementary Fig. S5). In mock-infected Caco2 cells, the ReIA
protein level in the nucleus was increased following TNF-α stimulation
(100 ng/mL) for 1 h, compared with mock-infected unstimulated cells.
Unexpectedly, in SA11-, huRV 1- and huRV2-infected Caco2 cells, the
nuclear accumulation of ReIA was also elevated following TNF-α
Fig. 3. Anti-rotavirus eﬀect of TNF-α is
mediated via TNF receptor 1 (TNFR1). (A)
qRT-PCR (n=4) and (B) western blot analysis
of TNFR1 knockdown by lentiviral sh-RNA
vectors in Caco2 cells. (C) TNFR1 knockdown
(sh-96) abolished TNFα-induced CXCL10 ex-
pression at 6 h following stimulation (n=6).
(D) TNFR1 knockdown (sh-96) led to the
blockade of TNFα-induced anti-rotavirus ac-
tivity at 48 h post-infections (n= 6). (E) The
TNF-α inhibitor (Inﬂiximab) (500 μg/mL) ab-
rogated the induction of CXCL10 gene fol-
lowing TNF-α stimulation (10 ng/mL) for 6 h
(n= 5). (F) Inﬂiximab (500 μg/mL) blocked
anti-rotavirus eﬀects of 10 ng/mL TNF-α as
measured by qRT-PCR at 48 h post infection
(n= 6). Data are presented as means ± SEM
(*P<0.05; **P<0.01; ***P<0.001; Mann-
Whitney test).
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stimulation (Supplementary Fig. S5).
4. Discussion
TNF-α was ﬁrst known for its anti-cancer activity in vitro (Carswell
et al., 1975). The subsequent development of recombinant technology
allowed the dissection of the multiple roles of TNF-α in the human
body, which includes inﬂammatory responses, immune regulatory
functions, and anti-microbial immunity (Sedger and McDermott, 2014).
Inappropriate regulation of TNF-α has been implicated in various
human diseases, leading to the use of TNF-α inhibitors in the clinic to
treat these TNFα-related diseases. The subsequent increased of viral
and bacterial infections in these patients suggests that TNF-α plays an
essential role in anti-viral and anti-microbial immunity (Kim and
Solomon, 2010).
Timely and rapid immune responses against invading viral patho-
gens are critical for the host to clear such infections. These early
responses mainly depend on anti-viral immunity mediated by innate
immune cells that produce various cytokines, such as IFNs, interleukins
and TNF-α that act directly to eliminate infections and indirectly by
promoting subsequent development of a more speciﬁc adaptive im-
munity (Holloway and Coulson, 2013). In infected children, increased
levels of IFN-α were detected in the blood, and related to the clinical
outcome (De Boissieu et al., 1993). Thus, investigating innate responses
is crucial for understanding virus-host pathogenesis during rotavirus
infections (Arnold et al., 2013).
Previous studies have shown the increased production of TNF-α by
DCs (Deal et al., 2010) and macrophages (Mohanty et al., 2010) upon
rotavirus stimulation. Elevated levels of TNF-α were found in children
with rotavirus diarrhea as compared to healthy controls (Azim et al.,
1999). Furthermore, in children with rotavirus diarrhea, a signiﬁcantly
higher level of TNF-α was found in serum of those who developed fever
and had more frequent episodes of diarrhea (Jiang et al., 2003). It is
probably associated with the eﬀect of TNF-α on ion secretion in human
Fig. 4. Anti-rotavirus eﬀect of TNF-α is
mediated via NF-κB signaling. (A) In Caco2-
based NF-κB reporter cell lines, TNF-α induced
activation of NF-κB-related luciferase signals in
a dose-dependent manner as measured at 12,
24 and 48 h, while AP1-related luciferase sig-
nals were not aﬀected (n=4–6). qRT-PCR
(n= 4) (B) and western blot (C) analysis of
ReIA (p65) knockdown by lentiviral sh-RNA
vectors in Caco2 cells. (D) ReIA (p65) knock-
down (sh-10) promoted rotavirus replication as
quantiﬁed by total RNA levels in Caco2 cells at
48 h post-infections (n= 8). (E) ReIA (p65)
knockdown (sh-10) led to the blockade of
TNFα-induced CXCL10 expression at 6 h post-
stimulations (n= 6). (F) ReIA knockdown (sh-
10) resulted in the blockade of TNFα-induced
anti-rotavirus activity at 48 h post-infections
(n= 6–8). Data are presented as
means ± SEM (*P<0.05; **P<0.01;
***P<0.001; ns, not signiﬁcant; Mann-
Whitney test).
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Fig. 5. TNFα-induced cytokines exert anti-
rotavirus activity. (A) Expression proﬁle of 33
cytokines in Caco2 cells as quantiﬁed by qRT-
PCR analysis. Some cytokines were up-regu-
lated with 10 ng/mL TNF-α stimulation of
Caco2 cells for 6 and 24 h (n=6). (B) IL32 A,
IL8, CXCL10, CXCL11, CCL20 and CCL2 sig-
niﬁcantly inhibited rotavirus replication as
quantiﬁed by qRT-PCR of total RNA levels,
both at 24 and 48 h (n= 6–8). (C)Western blot
analysis of VP4 protein indicates the inhibitory
eﬀect of 10 ng/mL of IL32, IL8, CXCL11 and
CCL20 against rotavirus at 48 h post-infections.
Data are presented as means ± SEM
(*P<0.05; **P<0.01; ***P<0.001; ns, not
signiﬁcant; Mann-Whitney test).
Fig. 6. Sensitivity of human rotavirus (huRV) clinical
strains to TNF-α treatment. TNF-α treatment for 48 h
(100 ng/mL) signiﬁcantly inhibits replication of huRV clinical
strain 1 (huRV 1) as measured by total rotavirus RNA levels in
Caco2 cells; while replication of huRV clinical strain 2 (huRV
2) was not aﬀected. (n=3, means ± SEM, **P<0.01,
Mann-Whitney test).
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intestinal epithelial cells (Oprins et al., 2000). This suggests that TNF-α
may contribute to the immunity and the disease pathogenesis. How-
ever, the exact role of TNF-α in rotavirus infection has not yet been
extensively studied. Here we demonstrated that TNF-α has a strong
anti-rotavirus eﬀect both at intracellular and extracellular (excreted)
levels. We also showed that the clinically used TNF-α inhibitors (in-
ﬂiximab) can completely block this eﬀect, supporting caution of the use
of these treatments in patients with latent or active viral infections.
In several cell lines, TNF-α induces the production of type I IFNs
(IFN-β) (Ahrens et al., 1990; Hughes et al., 1988; Jacobsen et al., 1989;
Yarilina et al., 2008). Thus, we ﬁrst hypothesized a straightforward
explanation that anti-rotavirus eﬀect of TNF-α is merely mediated via
type I IFN and consequently, classical IFN-signaling (JAK-STAT
pathway activation). However, treatment of Caco2 cells with TNF-α did
not signiﬁcantly increase ifna and ifnb1 gene expression levels, and
consequently did not result in IFN production (Fig. 2B and C). In ad-
dition, combination treatment with TNF-α and the pan-JAK I inhibitor
did not abolish the anti-rotavirus eﬀect of TNF-α. Thus, we conclude
that the anti-rotavirus eﬀect of TNF-α is independent of IFN production
and the JAK-STAT pathway.
TNF-α signals mainly through TNFR1 receptor and stimulates
downstream signaling pathways that ultimately activates two major
transcription factors, NF-κB (classical NF-κB pathway) and c-Jun (AP-1
pathway) (Cabal-Hierro and Lazo, 2012; Kalliolias and Ivashkiv, 2016).
Our experiments using Caco2-based NF-κB and AP-1 reporter cell lines
showed that TNF-α signals via NF-κB and not via AP-1. NF-κB is acti-
vated following rotavirus infection and is involved in the regulation of
cytokine productions (Rollo et al., 1999), indicating its importance in
the host defense against rotavirus. Indeed, the following loss-of-func-
tion assays by knocking down ReIA (p65), one of the main components
of the NF-κB protein complex, led to an increase of rotavirus replica-
tion. Furthermore, knockdown of ReIA abrogates anti-rotavirus eﬀect of
TNF-α. This indicates the importance of NF-κB in restricting rotavirus
infection and also in mediating anti-rotavirus eﬀects of TNF-α.
It is important to note that several studies have reported that other
rotavirus strains can inhibit NF-κB activation (Graﬀ et al., 2009) or its
TNFα-induced translocation to the nucleus (Holloway et al., 2009).
Noteworthy, the NSP1 protein of rotavirus contains a conserved C-
terminal phosphodegron-like (PDL) motif which disrupts NF-κB acti-
vation by interfering with IκB degradation (Morelli et al., 2015).
However, our data suggested that translocation of ReIA to the nucleus
was not blocked by SA11 as well as both human rotavirus strains 1 and
2, as demonstrated by confocal microscopy analysis (Fig. S5). Other
mechanisms, including blocking of ReIA binding to its promoter, may
be involved. Collectively, our results showed that anti-rotavirus eﬀect
of TNF-α is mediated via TNFR1 receptor and classical NF-κB signaling.
Several cytokines are induced following exposure of dendritic cells
to rotavirus, such as IL-6, IL-8, CXCL-10 and CCL5 (Deal et al., 2010;
Rosales-Martinez et al., 2016). Several cytokines have been associated
with clinical symptoms in rotavirus diarrheal children (Jiang et al.,
2003). Surprisingly, we found that TNFα-induced cytokines, such as IL-
8, CXCL10, CXCL11, have potent anti-rotavirus eﬀects. Further ex-
periments are therefore required to clarify their mechanism of action in
inhibiting rotavirus infection. Noteworthy, anti-TNFα treatment in
Crohn’s disease patients is associated with modulation of pro-in-
ﬂammatory genes, including IL1B and CXCL11 (Leal et al., 2015). Ac-
cordingly, our results from patients’ samples suggest that a high level of
TNF-α in serum may modulate rotavirus infection indirectly by af-
fecting cytokine levels in these patients’ sera.
It is important to note that under inﬂammatory conditions, infected
cells are continuously exposed to various cytokines. The eﬀect of these
cytokines could be inﬂuenced by the presence of other cytokines
(Bartee et al., 2008). Several studies have shown a synergistic anti-viral
eﬀect of TNF-α and type I IFNs (IFN-α and IFN-β) in the setting of HCV,
HEV (Wang et al., 2016), respiratory virus (Fink et al., 2013) and
poxvirus infections (Bartee et al., 2009). TNF-α can also synergize with
type II IFNs (IFN-γ) in the setting of cytomegalovirus (CMV) infection
(Lucin et al., 1994). Therefore, it is interesting to further investigate
whether these combined eﬀects can be observed in rotavirus infections.
5. Conclusion
We demonstrate a novel role of TNF-α in inhibiting rotavirus re-
plication. This anti-rotavirus eﬀect is mediated via the classical NF-κB
signaling pathway, independent of IFN production and JAK-STAT
pathway activity. Furthermore, this ﬁnding elucidates the increased
risk of viral infection upon TNF-α inhibitor treatments used in the
clinic. Thus, this knowledge may contribute to a better clinical man-
agement of these patients.
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